Stefan K. Alig, MD¹, Mohammad Shahrokh Esfahani, PhD^1*, Michael Y. Li, BS^2*, Ragini Malika Adams, MD^3*, Andrea Garofalo^4*, Michael C. Jin^5*, Mari Olsen^1*, Adèle Telenius^2*, Brian Sworder, MD, PhD⁶, Joseph Schroers-Martin, MD⁵, Daniel A. King, MD, PhD^1*, Cédric Rossi, MD, PhD^1*, Andre Schultz, PhD^1*, Karan R. Kathuria^1*, Chih Long Liu, PhD^5*, Valeria Spina^7*, Lieselot Buedts^8*, Jamie E. Flerlage, MD, MS⁹, Sharon M. Castellino, MD, MSc¹⁰, Ranjana H. Advani, MD¹¹, Davide Rossi, MD, PhD⁷, Ryan C. Lynch, MD¹², Olivier Casasnovas, MD^13*, David M. Kurtz, MD, PhD⁵, Lianna J. Marks, MD³, Michael P. Link, MD¹⁴, Marc André, MD^15*, Peter Vandenberghe, MD, PhD¹⁶, Christian Steidl^2*, Maximilian Diehn, MD, PhD^17* and Ash A. Alizadeh, MD, PhD¹⁸

¹Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
²Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
³Department of Pediatrics, Stanford University, Stanford, CA
⁴Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA
⁵Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁶Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁷Institute of Oncology Research, Bellinzona, Switzerland
⁸Department of Human Genetics, KU Leuven, Leuven, Belgium
⁹Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
¹⁰Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
¹¹Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
¹²Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA
¹³Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France
¹⁴Department of Pediatrics, Stanford University, Palo Alto, CA
¹⁵Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
¹⁶Department of Hematology & Department of Human Genetics, UZ & KU Leuven, Leuven, Belgium
¹⁷Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
¹⁸Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

Alex F. Herrera, MD¹, Ronald McCord, PhD^2*, Patrick Kimes, PhD^2*, Fabrice Jardin, MD, PhD^3*, Georg Lenz, MD, Prof.⁴, Marek Trneny, MD⁵, Christopher R. Flowers, MD⁶, Laurie H. Sehn, MD, MPH⁷, Gilles Salles, MD, PhD⁸, Jeff P. Sharman, MD⁹, Hervé Tilly, MD, PhD³, Jonathan W. Friedberg, MD, MMSc¹⁰, Charles Herbaux¹¹, Matthew J. Matasar, MD, MS⁸, Corinne Haioun, MD, PhD¹², Samuel Tracy, PhD^2*, Jamie Hirata, PharmD², Calvin Lee, MD², Yanwen Jiang, PhD^2* and Franck Morschhauser, MD, PhD^13*

¹City of Hope, Duarte, CA
²Genentech, Inc., South San Francisco, CA
³Centre Henri-Becquerel and University of Rouen, Rouen, France
⁴University Hospital Münster, Münster, Germany
⁵Charles University, General Hospital, Prague, Czech Republic
⁶M.D. Anderson Cancer Center, Houston, TX
⁷BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Willamette Valley Cancer Institute and Research Center, Florence, OR
¹⁰University of Rochester, Rochester, NY
¹¹University of Montpellier, Montpellier, France
¹²Groupe Hospitalier Henri Mondor-Chenevier, Créteil, France
¹³University of Lille, Centre Hospitalier Universitaire de Lille, Lille, France

Brian Sworder, MD, PhD¹, David M. Kurtz, MD, PhD¹, Stefan K. Alig, MD², Matthew J Frank, MD, PhD³, Navika D. Shukla, MD^4*, Andrea Garofalo^5*, Charles Macaulay, MSc, BA^5*, Mohammad Shahrokh Esfahani, PhD^2*, Mari Olsen^2*, James Hamilton III^6*, Hitomi Hosoya, MD, PhD⁶, Mark P Hamilton, MD⁷, Jay Y. Spiegel, MD, FRCPC⁸, John H. Baird, MD⁸, Mia Carleton^2*, Alexander F. M. Craig, MD, MPhil⁹, Sheren F. Younes, MD, PhD^10*, Bita Sahaf, PhD^8*, Natasha Sheybani, PhD^1*, Joseph Schroers-Martin, MD⁶, Chih Long Liu, PhD^6*, Jean S Oak, MD, PhD^10*, Michael C. Jin^6*, Sara Beygi Beygi, MD¹¹, Andreas Hüttmann, MD¹², Christine Hanoun^13*, Ulrich Dührsen, Prof, MD, PhD^13*, Jason Westin, MD¹⁴, Michael S. Khodadoust, MD PhD¹⁵, Yasodha Natkunam, MD, PhD¹⁶, Robbie G. Majzner, MD¹⁷, Crystal L. Mackall, MD^18,19, Maximilian Diehn, MD, PhD^20*, David B. Miklos, MD, PhD⁸ and Ash A. Alizadeh, MD, PhD²¹

¹Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁴Department of Medicine, Divisions of Hematology & Oncology, Stanford University, Palo Alto, CA
⁵Divisions of Oncology and Hematology, Stanford University School of Medicine, Stanford, CA
⁶Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁷Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁹Division of Oncology, Department of Medicine, Stanford University, Stanford, CA
¹⁰Department of Pathology, Stanford University School of Medicine, Stanford, CA
¹¹Divisions of Hematology and Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
¹²Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, NRW, Germany
¹³Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
¹⁴The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Department of Medicine, Division of Oncology & Department of Dermatology, Stanford University School of Medicine, Stanford, CA
¹⁶Stanford University School of Medicine, Stanford, CA
¹⁷Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
¹⁸Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
¹⁹Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
²⁰Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
²¹Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

Eva Hoster^1,2*, Marie-Helene Delfau^3,4*, Elizabeth A. Macintyre, PhD, FRCP, FRCPath^5,6, Linmiao Jiang, MSc^1*, Stephan Stilgenbauer, MD⁷, Ursula Vehling-Kaiser^8*, Gilles Salles, MD, PhD^9,10, Catherine Thieblemont, MD, PhD¹¹, Hervé Tilly, MD, PhD¹², Lothar Kanz¹³, Pierre Feugier, MD^14*, Kai Huebel, MD^15*, Christian Schmidt, MD^2*, Vincent Ribrag, MD¹⁶, Hanneke Kluin-Nelemans, MD^17*, Martin Dreyling, MD² and Christiane Pott^18*

¹Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany
²Department of Internal Medicine III, LMU University Hospital, Munich, Germany
³Immunology Biology, Mondor University Hospital, Créteil, France
⁴INSERMU955 équipe 9, Institut Mondor de Recherche Biomédicale, Créteil, France
⁵Institut Necker Enfants Malades, Université de Paris (Descartes), Paris, France
⁶Laboratory of Onco-Hematology, Necker University Hospital, Paris, France
⁷Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
⁸UBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut, Germany
⁹Hospices Civils de Lyon, Université Claude Bernard, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
¹⁰Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Hemato-Oncology, Hôpital Saint-Louis, APHP, University of Paris, Paris, France
¹²Department of Hematology and U1245, Centre Henri Becquerel and University of Rouen, Rouen, France
¹³Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
¹⁴Department of Hematology, Henri Poincaré University, CHU NANCY BRABOIS, Vandoeuvre Les Nancy, France
¹⁵Klinik I für Innere Medizin, University of Cologne, Cologne, Germany
¹⁶DITEP-Hematology, Inserm U1170, Institut Gustave Roussy, Villejuif, France
¹⁷Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
¹⁸Clinic for Internal Medicine II - Haematology, Oncology, University Clinic Schleswig-Holstein, Kiel, Germany

Herve Ghesquieres, MD, PhD^1*, Youenn Drouet, PhD^2*, Susan L. Slager, PhD³, Franck Morschhauser, MD, PhD^4*, Sara Galimberti, MD^5*, Dennis P. Robinson^3*, Emilie Thomas^6*, Anne J. Novak, PhD⁷, Luc Xerri, MD, PhD^8*, Stefano Luminari, MD⁹, Aurelie Verney^10*, Camille Laurent, MD, PhD^11*, Lisa M. Rimsza, MD¹², Thomas M. Habermann, MD¹³, Massimo Federico, MD¹⁴, Brian K. Link, MD¹⁵, Gilles Salles, MD, PhD¹⁶ and James R. Cerhan, MD, PhD³

¹Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
²Prevention and genetic epidemiology Unit, Centre Leon Berard, Lyon, France
³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁴Service des Maladies du Sang, CHU Lille, Lille, France
⁵UO Ematologia, Azienda Ospedaliero Universitaria Pisana, Pisana, Italy
⁶Centre Leon Berard, Centre de recherche en cancérologie de Lyon, INSERM 1052, CNRS 5286, Lyon, France
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Bio-Pathology Department, Institute Paoli-Calmettes, Marseille, France
⁹Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, REGGIO EMILIA, Italy
¹⁰Centre International de Recherche en Infectiologie, Lymphoma Immuno Biology Team, INSERM 1111, Université Claude Bernard Lyon 1, Lyon, France
¹¹Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France; Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Université Toulouse III-Paul-Sabatier, Toulouse, France
¹²Division of Hematopathology, Mayo Clinic - Scottsdale, Scottsdale, AZ
¹³Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹⁴Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
¹⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Laura K Hilton, PhD^1,2*, Henry S. Ngu^2*, Brett Collinge^2,3*, Kostiantyn Dreval, PhD^1,4*, Susana Ben-Neriah, MSc^2*, Christopher K Rushton^1*, Jasper Wong^2*, Manuela Cruz, BSc^1*, Andrew Roth^5*, Merrill Boyle, BSc^2*, Barbara Meissner^2*, Graham W. Slack, MD^2,3, Pedro Farinha, MD, PhD^2,3*, Jeffrey W. Craig, MD, PhD^2,3*, Alina S. Gerrie, MD, MPH, FRCPC^2,6, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP⁷, Diego Villa, MD^2,6, Kerry J. Savage, MD, MSc, FRCPC^2,6, Laurie H. Sehn, MD, MPH^2,6, Marco A. Marra^2,4,8, Aly Karsan, MD⁴, Christian Steidl^2,3*, Ryan D. Morin^2,4,9 and David W. Scott, PhD, MD, FRACP, FRCPA^2,10

¹Department of Molecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada
²Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
³Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
⁴Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
⁵BC Cancer, Department of Molecular Oncology, Vancouver, BC, Canada
⁶Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
⁷Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁸Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
⁹Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
¹⁰Department of Medicine, University of British Columbia, Vancouver, BC, Canada